Easing the Challenges of Global Feasibility: Strategies to Balance Priorities, Manage Disparate Data Sources and Mitigate Risk

In this informative webinar, explore the challenges of global feasibility and gain insights into strategies for successful study start-ups, including protocol optimization, geostrategy and site selection. Global feasibility is the linchpin of successful study start-ups, but it is not a cut-and-dry process. Successful feasibility goes beyond choosing the right countries and the right sites with proximity to the target patient population. It also requires the careful balance of competing organizational priorities from different stakeholders with the potential risks that each presents.

How do clinical experts find a compromise between stakeholders when evaluating protocol optimization, geostrategy, site selection and delivery performance? In this webinar, global feasibility and clinical operations experts from Regeneron and Parexel will share their insights, best practices and case studies on global feasibility strategies.

The panel of experts will share insights on:

• The complexity of modeling modern protocols, incorporating assumptions that are meaningful for operational delivery
• Managing disparate data sources to drive data-rich conclusions about the best strategies, study and country performance and optimal solutions to balance risk and ambition
• Creating a viable site universe to prepare for future studies, optimize engagement and thereby fast-track site selection
• Encompassing patient experiences and understanding their standard of care alternatives in understanding the motivation for clinical trial participation
• Training teams on what data are most relevant to assess future risk

Join this webinar to explore strategies including protocol optimization, geostrategy and site selection to strike a balance between risk and ambition.

Speakers

Amy Froment, Senior Director, Head of Global Trial Optimization, Regeneron

Info coming soon.

Message Presenter

Denis McMillan, Vice President, Global Feasibility, Parexel

Denis McMillan is responsible for the management and leadership of the Phase II/III solution consultant team and global strategic feasibility group encompassing 50 dedicated staff worldwide.

Denis is an expert in bid management, clinical strategy development and strategic feasibility. He has headed departments of varying sizes for over 15 years and consistently delivered innovation and results while fostering a positive team environment. Denis was specifically brought into ICON and then PPD to change the paradigm in business development and feasibility respectively to deliver expert, value-orientated products. He has rare insight into the challenges of delivering trials at research sites from five years of working in a site management organization.

Message Presenter

Camilla Ramdeen, PhD, Executive Director, Strategic Feasibility, Parexel

Dr. Camilla Ramdeen has led the global strategic feasibility team at Parexel since 2015 and has 16 years of CRO-based clinical research experience in feasibility and strategy, study start-up leadership, project management, investigator relationships and patient recruitment roles. Prior to joining the industry, she worked as an Oncology Dietitian and Academic Researcher at the Royal Marsden Hospital in London.

Message Presenter